How do I contact Ted Xutian Jing?

Ted Xutian Jing, Managing Director at 5Y Capital, can be reached by email. The verified email address is listed on this page.

What is Ted Xutian Jing's email address?

Ted Xutian Jing's email address uses the 5ycap.com domain (shown as *****@5ycap.com until revealed).

What does Ted Xutian Jing invest in?

Ted Xutian Jing backs Health tech companies at Series A and Seed, typically writing €92k–€4.6M cheques.

How do I cold email Ted Xutian Jing?

Ted Xutian Jing backs Health tech companies at Series A and Seed, writing €92k–€4.6M cheques. A concise cold email that leads with relevant traction and one specific ask, sent to the verified address on this page, is the most direct way to reach Ted.

Where is Ted Xutian Jing based?

Ted Xutian Jing is based in Shanghai, China and works at 5Y Capital.

Ted Xutian Jing Email & Contact Information

Managing Director @ 5Y Capital

Show Ted's email

Ted Xutian Jing Location

Shanghai, China

Ted Xutian Jing Investing

Managing Director at 5Y Capital

Stages: Series A, Seed
Sectors: Health tech
Cheque size: €92k–€4.6M
Fund size: $5B
Freshness: Verified 1mo ago

Ted Xutian Jing Summary

Ted Xutian Jing, based in Shanghai, China, is a Managing Director at 5Y Capital. Ted Xutian Jing invests in Health tech at Series A and Seed, writing €92k–€4.6M cheques. Ted Xutian Jing's verified email and contact details are available on Mintround.

How to cold email Ted Xutian Jing

Ted Xutian Jing, 5Y Capital in Shanghai, China, backs Health tech companies at Series A and Seed, writing €92k–€4.6M cheques. Here's how to get a reply when you cold email Ted:

Subject line: name your company and one metric that matters to Health tech, not “quick chat”.
First line: your strongest traction, the real numbers, not adjectives.
One ask: a 20-minute call with a date range. Keep it under 150 words.
Send it to Ted's verified address below. No warm intro required.

Show Ted's email

Notable investments

Aureka BiotechnologiesSeries A · $35M · 2026
Zhongke GuoshengSeries A · $28M · 2025
ReviR TherapeuticsSeries A · $30M · 2024
Regenerative BioAngel · $10M · 2022
Abogen BiosciencesSeries C · $300M · 2021
Polaris BiologySeries A · $8M · 2019

Frequently co-invests with

Wei GuoUpHonest CapitalWilliam HuQiming Venture Partners

Ted Xutian Jing's colleagues at 5Y Capital

Jerry TongSenior Associate, 5Y Capital

Richard LiuGeneral Partner, 5Y Capital

Yu ChengPartner, 5Y Capital

Peter Zhe ChenManaging Director, 5Y Capital

Elwin YuanPartner, 5Y Capital

Ken ShiInvestor, 5Y Capital

Fisher ZhangPartner, 5Y Capital

Levi LiuPartner, 5Y Capital

See all 9 at 5Y Capital →

Similar investors

Bing ZhuoInvestor, BVCF (Bioveda China Fund)

Ron CaoVenture Partner, Sky9 Capital

Shuo MaoVice President, Qiming Venture Partners

William HuManaging Partner, Qiming Venture Partners

Nisa LeungManaging Partner, Qiming Venture Partners